Indeed, in vivo models of cancer have also demonstrated how overactive MYC enhances the expression of the ICMs CD47 and PD-L1 [36], as well as the anti-immune signalling molecules IL-23 and CCL9 (Fig. 1, Fig. 2) [37]. The gene discussed is CD274; the disease is cancer.